(Q36834289)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17535043%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Conventional and atypical antipsychotics in the elderly : a review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17535043%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17535043%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Giovambattista De Sarro

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17535043%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Pietro Gareri

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17535043%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Mariagrazia Stilo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17535043%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Guido Ferreri

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17535043%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17535043%20AND%20SRC:MED&resulttype=core&format=json

Clinical Drug Investigation

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17535043%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17535043%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17535043%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

287-322

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17535043%20AND%20SRC:MED&resulttype=core&format=json

The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00044011-200323050-00001

A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00044011-200323050-00001

Risperidone treatment of behavioral disturbances in outpatients with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00044011-200323050-00001

The role of serotonin in antipsychotic drug action

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00044011-200323050-00001

Olanzapine for psychosis in patients with Parkinson's disease with and without dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00044011-200323050-00001

The pharmacokinetics of remoxipride and metabolites in patients with various degrees of renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00044011-200323050-00001

The new antipsychotic compounds: is a clinical choice algorithm possible?

21 January 2018

1 reference

12 December 2020

Olanzapine use in the elderly: a retrospective analysis

1 reference

12 December 2020

The long-term effect of quetiapine (Seroquel TM ) monotherapy on weight in patients with schizophrenia

1 reference

12 December 2020

Genetically determined variability in acetylation and oxidation. Therapeutic implications

1 reference

12 December 2020

Risperidone in the treatment of elderly patients with psychotic disorders

1 reference

12 December 2020

Comparison of in vitro binding properties of a series of dopamine antagonists and agonists for cloned human dopamine D2S and D2L receptors and for D2 receptors in rat striatal and mesolimbic tissues, using [125I] 2'-iodospiperone

1 reference

12 December 2020

Diabetes mellitus in schizophrenic patients

1 reference

12 December 2020

Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients.

1 reference

12 December 2020

Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties.

1 reference

12 December 2020

Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group

1 reference

12 December 2020

Olanzapine therapy in treatment-resistant psychotic mood disorders: a long-term follow-up study

1 reference

12 December 2020

Involvement of cholinergic presynaptic receptors of nicotinic and muscarinic types in the control of the spontaneous release of dopamine from striatal dopaminergic terminals in the rat.

1 reference

12 December 2020

Excitatory amino acids: implications for psychiatric disorders research

1 reference

12 December 2020

Tardive dyskinesia treated with pimozide

1 reference

12 December 2020

Efficacy and tolerability of olanzapine in elderly patients with psychotic disorders: a prospective study

1 reference

12 December 2020

1 reference

12 December 2020

Clinical experience with risperidone, haloperidol, and thioridazine for dementia-associated behavioral disturbances

1 reference

12 December 2020

Antidepressant drugs in the elderly.

1 reference

12 December 2020

Psychotropic drugs and the ECG: focus on the QTc interval

1 reference

12 December 2020

Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist

1 reference

12 December 2020

Cytochromes P450 expression systems

1 reference

12 December 2020

Two cases of deep vein thrombosis associated with a combined paroxetine and zotepine therapy

1 reference

12 December 2020

Schizophrenia and glutamatergic transmission

1 reference

12 December 2020

Care of depression in the elderly: comparative pharmacokinetics of SSRIs

1 reference

12 December 2020

Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group

1 reference

12 December 2020

New onset diabetes and atypical antipsychotics

1 reference

12 December 2020

Cognitive dysfunction in schizophrenia: comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs.

1 reference

12 December 2020

Facilitation of glutamate receptors enhances memory

1 reference

12 December 2020

In vivo extrastriatal and striatal D2 dopamine receptor blockade by amisulpride in schizophrenia

1 reference

12 December 2020

Atypical antipsychotics. Part I: Pharmacology, pharmacokinetics, and efficacy

1 reference

12 December 2020

Antipsychotic medications and the elderly: effects on cognition and implications for use.

1 reference

12 December 2020

International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin)

1 reference

12 December 2020

Risperidone-associated new-onset diabetes

1 reference

12 December 2020

Pharmacokinetics of clozapine and risperidone: a review of recent literature

1 reference

12 December 2020

Stimulatory effect of L-glutamate and related amino acids on [3H]dopamine release from rat striatum: an in vitro model for glutamate actions

1 reference

12 December 2020

Drug-Metabolizing Enzymes and Therapeutic Drug Monitoring in Psychiatry

1 reference

12 December 2020

Dopamine receptors and brain function.

1 reference

12 December 2020

Antipsychotic medication: effects on regulation of glucose and lipids

1 reference

12 December 2020

Effects of pH and ascorbic acid on 3H-spiperone and 3H-dihydroalprenolol binding in rat forebrain homogenates

1 reference

12 December 2020

[N-dimethylamino-prophylchlorophenothiazine (4560 RP) therapy of confusional states]

1 reference

12 December 2020

Increased [3H]kainic acid binding in the prefrontal cortex in schizophrenia.

1 reference

12 December 2020

Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders

1 reference

12 December 2020

Use of haloperidol infusions to control delirium in critically ill adults.

1 reference

12 December 2020

Quetiapine fumarate overdose: clinical and pharmacokinetic lessons from extreme conditions.

1 reference

12 December 2020

Clinical pharmacokinetics of remoxipride.

1 reference

12 December 2020

Risperidone for the treatment of behavioral disturbances in dementia: a case series

1 reference

12 December 2020

Atypical antipsychotics: mechanism of action.

1 reference

12 December 2020

CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages

1 reference

12 December 2020

A "glutamatergic hypothesis" of schizophrenia. Rationale for pharmacotherapy with glycine.

1 reference

12 December 2020

Recent advances in the molecular biology of dopamine receptors

1 reference

12 December 2020

Schizophrenia and L-745,870, a novel dopamine D4 receptor antagonist

1 reference

12 December 2020

The dopamine D1D receptor. Cloning and characterization of three pharmacologically distinct D1-like receptors from Gallus domesticus

1 reference

12 December 2020

Classification and nomenclature of 5-HT receptors: a comment on current issues

1 reference

12 December 2020

Enhancement by an ampakine of memory encoding in humans.

1 reference

12 December 2020

Effect of risperidone on QT interval and QT dispersion in the elderly

1 reference

12 December 2020

A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia

1 reference

12 December 2020

Risk factors in geriatric drug prescribing. A practical guide to avoiding problems

1 reference

12 December 2020

Conventional and new antidepressant drugs in the elderly

1 reference

12 December 2020

The phencyclidine psychosis: phenomenology and treatment

1 reference

12 December 2020

An atypical neuroleptic drug in the treatment of behavioural disturbances and psychotic symptoms in elderly people

1 reference

12 December 2020

Negative v positive schizophrenia. Definition and validation.

1 reference

12 December 2020

Olanzapine-induced diabetes mellitus

1 reference

12 December 2020

In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone

1 reference

12 December 2020

Ziprasidone: an atypical antipsychotic drug for the treatment of schizophrenia

1 reference

12 December 2020

The family history in clinical psychiatric practice.

1 reference

12 December 2020

Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquine

1 reference

12 December 2020

Characterization of the common genetic defect in humans deficient in debrisoquine metabolism

1 reference

12 December 2020

Management of psychosis in Parkinson's disease

1 reference

12 December 2020

Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. Seroquel Trial 48 Study Group.

1 reference

12 December 2020

Clozapine-associated elevation in serum triglycerides

1 reference

12 December 2020

Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain.

1 reference

12 December 2020

NMDA-associated glycine binding site increases in schizophrenic brains

1 reference

12 December 2020

Ziprasidone: a new atypical antipsychotic

1 reference

12 December 2020

Antipsychotic-Induced movement disorders in the elderly: epidemiology and treatment recommendations

1 reference

12 December 2020

Psychotic symptoms and paranoid ideation in a nondemented population-based sample of the very old

1 reference

12 December 2020

Management of drug therapy in the elderly

1 reference

12 December 2020

Metabolism of thioridazine in the elderly

1 reference

12 December 2020

Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease

1 reference

12 December 2020

Atypical antipsychotics and hyperglycaemia

1 reference

12 December 2020

Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors

1 reference

12 December 2020

A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis. On behalf of the Risperidone Working Group

1 reference

12 December 2020

Pharmacokinetics of sertindole in healthy young and elderly male and female subjects.

1 reference

12 December 2020

Survey on the pharmacodynamics of the new antipsychotic risperidone

1 reference

12 December 2020

Striatal dopamine-2 receptor occupancy as measured with [123I]iodobenzamide and SPECT predicted the occurrence of EPS in patients treated with atypical antipsychotics and haloperidol

1 reference

12 December 2020

Sleep disorders in patients with severe mental depression: Double-blind placebo-controlled evaluation of the value of pipamperone (Dipiperon®)

1 reference

12 December 2020

Clozapine-induced diabetic ketoacidosis

1 reference

12 December 2020

Deficient NMDA-mediated glutamate release from synaptosomes of schizophrenics

1 reference

12 December 2020

Biological research on schizophrenia

1 reference

12 December 2020

Phencyclidine and analogues: effects on brain protein synthesis.

1 reference

12 December 2020

5-HT3 receptor antagonists reverse helpless behaviour in rats

1 reference

12 December 2020

Plasma protein binding of risperidone and its distribution in blood

1 reference

12 December 2020

Evidence of glutamatergic deficiency in schizophrenia

1 reference

12 December 2020

Acute antagonism of dopamine D2-like receptors by amisulpride: effects on hormone secretion in healthy volunteers

1 reference

12 December 2020

[Treatment of negative symptoms in schizophrenia by amisulpride. Review of the literature]

1 reference

12 December 2020

Effects of an AMPA receptor modulator on methamphetamine-induced hyperactivity in rats

1 reference

12 December 2020

Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents

1 reference

12 December 2020

Positron emission tomography of in-vivo binding characteristics of atypical antipsychotic drugs. Review of D2 and 5-HT2 receptor occupancy studies and clinical response.

1 reference

12 December 2020

Serotonin2 receptor-mediated excitation of interneurons in piriform cortex: antagonism by atypical antipsychotic drugs

1 reference

12 December 2020

Multiple human D5 dopamine receptor genes: a functional receptor and two pseudogenes

1 reference

12 December 2020

Would a switch from typical antipsychotics to risperidone be beneficial for elderly schizophrenic patients? A naturalistic, long-term, retrospective, comparative study

1 reference

12 December 2020

Effects of antipsychotic drugs on serotonin receptors

1 reference

12 December 2020

Effect of age and sex on the plasma binding of acidic and basic drugs

1 reference

12 December 2020

Comparative study of mortality rates and cardiac dysrhythmias in post-marketing surveillance studies of sertindole and two other atypical antipsychotic drugs, risperidone and olanzapine

1 reference

12 December 2020

The pharmacokinetics of tricyclic antidepressant drugs in the elderly

1 reference

12 December 2020

Convulsive seizures in schizophrenic patients induced by zotepine administration

1 reference

12 December 2020

Antidepressant drug therapy in the elderly--a critical review of the controlled clinical trials conducted since 1980.

1 reference

12 December 2020

The glutamatergic dysfunction hypothesis for schizophrenia

1 reference

12 December 2020

Dopaminergic modulation of glutamate release in striatum as measured by microdialysis

1 reference

12 December 2020

1 reference

12 December 2020

The natural course of schizophrenia and effective maintenance drug treatment

1 reference

12 December 2020

[Social and environmental factors and mental health in the elderly]

1 reference

12 December 2020

Strategy for modulation of central dopamine transmission based on the partial agonist concept in schizophrenia therapy

1 reference

12 December 2020

Monitoring plasma levels of fluphenazine during chronic therapy with fluphenazine decanoate.

1 reference

12 December 2020

Geriatric drug therapy

1 reference

12 December 2020

(3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients

1 reference

12 December 2020

Recent advances in the phencyclidine model of schizophrenia

1 reference

12 December 2020

Pharmacogenetics and drug metabolism of newer antidepressant agents.

1 reference

12 December 2020

Use of olanzapine for elderly patients with psychotic disorders: a review

1 reference

12 December 2020

Single- and multiple-dose pharmacokinetics of ziprasidone in healthy young and elderly volunteers

1 reference

12 December 2020

Drug therapy: drug disposition in old age.

1 reference

12 December 2020

The central cholinergic system profile of olanzapine compared with placebo in Alzheimer's disease

1 reference

12 December 2020

3H-spiroperidol labels dopamine receptors in pituitary and brain

1 reference

12 December 2020

The effect of intravenous haloperidol on QT interval dispersion in critically ill patients: comparison with QT interval prolongation for assessment of risk of Torsades de Pointes

1 reference

12 December 2020

Characterization and distribution of putative 5-ht7 receptors in guinea-pig brain

1 reference

12 December 2020

Autism and associated behavioral disorders: pharmacotherapeutic intervention

1 reference

12 December 2020

[Drug therapy of elderly patients]

1 reference

12 December 2020

Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia.

1 reference

12 December 2020

Effects of a memory-enhancing drug on DL-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor currents and synaptic transmission in hippocampus

1 reference

12 December 2020

Centrally active modulators of glutamate receptors facilitate the induction of long-term potentiation in vivo

1 reference

12 December 2020

Pharmacokinetics of risperidone in chronic schizophrenic patients.

1 reference

12 December 2020

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

1 reference

12 December 2020

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

1 reference

12 December 2020

Risperidone in the treatment of behavioral disorders in elderly patients with dementia

1 reference

12 December 2020

The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs

1 reference

12 December 2020

Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3)

1 reference

12 December 2020

A pharmacological, pharmacokinetic and clinical overview of risperidone, a new antipsychotic that blocks serotonin 5-HT2 and dopamine D2 receptors.

1 reference

12 December 2020

Management of late-life psychosis

1 reference

12 December 2020

Influence of amphetamines on animal behaviour: stereotypy, functional impairment and possible animal-human correlations.

1 reference

12 December 2020

Alterations in phencyclidine and sigma binding sites in schizophrenic brains. Effects of disease process and neuroleptic medication

1 reference

12 December 2020

5-HT2 antagonist ritanserin in neuroleptic-induced parkinsonism: a double-blind comparison with orphenadrine and placebo.

1 reference

12 December 2020

Pharmacokinetic interactions involving clozapine

1 reference

12 December 2020

AMPA receptor binding and subunit mRNA expression in prefrontal cortex and striatum of elderly schizophrenics

1 reference

12 December 2020

Correlation of estimated renal function parameters versus 24-hour creatinine clearance in ambulatory elderly

1 reference

12 December 2020

Serum triglyceride levels in patients treated with clozapine

1 reference

12 December 2020

Ageing and its effects on the cardiovascular system

1 reference

12 December 2020

A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical data

1 reference

12 December 2020

Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective

1 reference

12 December 2020

Novel antipsychotics and new onset diabetes

1 reference

12 December 2020

Phencyclidine for analgesia and anesthesia in simian primates.

1 reference

12 December 2020

Neurobiology of schizophrenia

1 reference

12 December 2020

Problems in classification of schizophrenics as neuroleptic responders and nonresponders

1 reference

12 December 2020

Shifting from haloperidol to risperidone for behavioral disturbances in dementia: safety, response predictors, and mood effects

1 reference

12 December 2020

Pipamperone (Dipiperon) in the treatment of behaviour disorders. A large-scale multicentre evaluation

1 reference

12 December 2020

Modulation of striatal [3H]-glutamic acid release by dopaminergic drugs

1 reference

12 December 2020

The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate

1 reference

12 December 2020

Phencyclidine: an overview

1 reference

12 December 2020

Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients

1 reference

12 December 2020

The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function

1 reference

12 December 2020

A placebo-controlled pilot study of the ampakine CX516 added to clozapine in schizophrenia

1 reference

12 December 2020

Dopamine receptors: molecular biology, biochemistry and behavioural aspects

1 reference

12 December 2020

Drug-drug interactions involving antidepressants: focus on venlafaxine

1 reference

12 December 2020

D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons

1 reference

12 December 2020

In vivo presynaptic control of dopamine release in the cat caudate nucleus--II. Facilitatory or inhibitory influence of L-glutamate

1 reference

12 December 2020

Long-Term use of quetiapine in elderly patients with psychotic disorders

1 reference

12 December 2020

GABA-ergic neurons and the neurobiology of schizophrenia and other psychoses

1 reference

12 December 2020

Single dose pharmacodynamics of thioridazine and remoxipride in healthy younger and older volunteers

1 reference

12 December 2020

Atypical tricyclic neuroleptics for treatment of schizophrenia. Clothiapine and clozapine

1 reference

12 December 2020

Zotepine in the prevention of recurrence: a randomised, double-blind, placebo-controlled study for chronic schizophrenia.

1 reference

12 December 2020

Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy

1 reference

12 December 2020

Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors

1 reference

12 December 2020

Phencyclidine-induced psychosis

1 reference

12 December 2020

Aspartate-releasing nerve terminals in rat striatum possess D-2 dopamine receptors mediating inhibition of release

1 reference

12 December 2020

The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function

1 reference

12 December 2020

Positive and negative symptoms, depression and social disability in chronic schizophrenia: a comparative trial of bromperidol and fluphenazine decanoates

1 reference

12 December 2020

Clinical experience with quetiapine in elderly patients with psychotic disorders

1 reference

12 December 2020

A structured trial of risperidone for the treatment of agitation in dementia.

1 reference

12 December 2020

Presynaptic regulation of neurotransmitter release in the brain: Facts and hypothesis

1 reference

12 December 2020

Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis. Ziprasidone I.M. Study Group.

1 reference

12 December 2020